Hos de fleste patienter steg det atherogene indeks ikke, og stigningerne i total cholesterol responderede på behandling med lipidsænkende midler.
In the majority of patients, there was no increase in atherogenic indices, and elevations in total cholesterol responded to treatment with lipid lowering agents.